Stately Bio raises $12M in seed funding, led by AIX Ventures. The funding will be used to scale its ML-powered live-cell imaging platform.
May 01, 2025•3 months ago
Amount Raised
$12 Million
Round Type
seed
Investors
Tom BerryJeremy WertheimerJeff DeanAxial VcBox One VenturesMitsui Global InvestmentCaffeinated CapitalVillage GlobalFoothill VenturesDimension CapitalAix Ventures
Description
Stately Bio, a Palo Alto based startup, has raised $12M in seed funding. The round was led by AIX Ventures with multiple investors including Dimension Capital and Foothill Ventures. The company plans to use the funding to enhance its technology and develop stem cell-derived therapeutics. Founded in 2022, Stately Bio is focusing on using machine learning in regenerative medicine.
FundzWatch™ Score
72
Medium Activity
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech